FDA cleared for automated imaging & analysis of amniotic cells hybridized with X,Y,18,13,21 probes
Automated scanning, classification and analysis of amniotic cells hybridized with fluorescent probes, enables fast and accurate detection of chromosomal abnormalities related to chromosomes 13, 18, 21, X and Y.
The application is not available in all markets.
For additional information visit our Regulatory Approvals Page